Search results for: COVID-19 Research
Filter search results
Sarin KC
4 September 2024
…supported the institutionalisation of HTA in several countries including Bhutan, Ghana, and India. During the COVID-19 pandemic, his work focused on strengthening the use of infectious disease modelling for urgent…
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
…the timely diagnosis of HF. The use of point-of-care devices, notably, has been valuable during the COVID-19 pandemic by enabling real-time monitoring of HF patients. The information generated by these…
‘HispaNICE’: the Creation of an ‘Independent Authority for the Evaluation of Health Practices and Policies’ Gathers Momentum
24 February 2021
…Health and Health Administration. The signatories explained that the crisis brought on by COVID-19 has exposed important drawbacks of the Spanish National Health System (SNHS). The document focuses on what…
International Women’s Day: Why We #Choosetochallenge
8 March 2021
…moving up the stages of an academic career; gender bias in teaching evaluations; unequal share of household chores; and the highest uptake of home schooling in lockdown during the Covid-19…
The NICE Health Technology Evaluation Manual: A Fresh Perspective Needed?
16 March 2022
…a world facing many challenges – from the devasting effect of COVID-19 on health systems worldwide to climate change and political instability. How we allocate public sector resources to address…
After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
1 November 2021
…result of the COVID-19 pandemic. Legislative changes such as ‘presumed consent’, which requires individuals to ‘opt out’ of automatic organ donation, are seeking to increase the number of organs donated…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…can be redeployed in lots of areas – for example the mRNA technology that underpins some of the successful Covid-19 vaccines was developed for use in cancer. Reductions in the…
The CBO Doesn’t Understand Investors
13 September 2021
…have adverse consequences for population health—both in the US and globally. In the face of rapid scientific progress, such as we have seen with the development of COVID-19 vaccines and…
H.R. 3 is the Wrong Policy for the Wrong Problem
10 September 2021
…of pre-existing mRNA platforms that allowed for the rapid development of COVID-19 vaccines. These positive externalities must be considered when evaluating a policy such as H.R. 3, which could have…